A comparison of patient self-referrals and general practitioner referrals to the emergency department in Ireland during the COVID-19 pandemic: secondary data analysis of the "Better Data, Better Planning" study
Abstract
BACKGROUND
Internationally crowding in Emergency Departments (ED) has become a public health issue. In Ireland, primary care is centred around General Practitioners who can refer patients with acute illnesses or injuries to the ED. Patients can also choose to go directly to the ED if they require emergency care and self-referrals to the ED have been rising in recent years.
AIM
The study aims to describe the demographic and clinical characteristics of patients who self-referred compared to patients referred by GPs in Irish EDs during the COVID-19 pandemic.
METHODS
This was a secondary data analysis of a cross-sectional, multi-centre study describing Irish ED utilisation; the Better Data, Better Planning (BDBP) Study. Descriptive comparisons were made between GP referrals to the ED and self-referrals in relation to; demographics, clinical data, healthcare utilisation, service awareness and other factors, with data being analysed in SPSS.
RESULTS
Demographic differences were minimal however significant differences were observed between GP referrals and self-referrals for; types of clinical presentations (p < 0.05), duration of complaint (p < 0.001), awareness of other services (p < 0.05), need for reassurance (p < 0.001), acquiring a second opinion (p < 0.05) and utilisation of GPs over the year (p < 0.05).
CONCLUSION
Demographics were similar between GP referrals and self-referrals to the ED however significant behavioural and clinical differences were observed across groups.…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.